MedTrace Logo

AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

NCT04006405 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2025-06-15

No results posted yet for this study

Summary

AUR87A is an observational prospective multicenter diagnostics test cohort study for detection of renal cell carcinoma recurrence as determined by the reference standard, which is imaging using computed tomography (CT) of the chest and abdomen at defined intervals after primary surgery.

Conditions

Interventions

DIAGNOSTIC_TEST

GAG score

blood and urine samples to determine GAG scores

Sponsors & Collaborators

  • Elypta

    lead INDUSTRY

Principal Investigators

  • Saeed Dabestani · Lund University, Dept. Clinical Sciences, Skåne University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-10
Primary Completion
2025-05-07
Completion
2025-05-07

Countries

  • United States
  • Belgium
  • Canada
  • Denmark
  • Finland
  • France
  • Italy
  • Portugal
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04006405 on ClinicalTrials.gov